Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACYW135 meningococcal conjugate vaccine in 3–5 month infants
CTR20212286Phase 3Completed
- Sponsor
- Beijing Luzhu Biotechnology
- Start
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal (group A, C, Y, W135) polysaccharide conjugate vaccine in meningococcal disease, sponsored by Beijing Luzhu Biotechnology. Started Sep 2021; status: completed.
02
Drugs
meningococcal (group A, C, Y, W135) polysaccharide conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on CTR20212286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212286.